XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 51,458 $ 60,964
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on sale of business 0 (14,533)
Depreciation and amortization 23,095 21,217
Amortization of debt issue costs 289 289
Provision for doubtful accounts 7,699 5,863
Share-based compensation 8,388 7,729
Deferred income taxes 1,938 (1,565)
Change in fair value of contingent consideration 2,047 0
Finance lease interest 69 70
Changes in operating assets and liabilities:    
Accounts receivable 13,441 143,774
Inventories 34,576 226,878
Prepaid expenses and other assets 8,013 (28,163)
Other non-current assets 4,344 6,022
Accounts payable (50,359) (117,860)
Accrued expenses and other liabilities (5,632) 11,338
Income taxes payable 5,338 (5,115)
Net cash provided by operating activities 104,704 316,908
Cash flows from investing activities:    
Capital expenditures (5,769) (7,285)
Cash paid for business acquisitions, net of cash acquired (56,673) 0
Proceeds from sale of business, net of cash transferred 2,569 17,978
Net cash (used in) provided by investing activities (59,873) 10,693
Cash flows from financing activities:    
Borrowings on revolving credit 38,336 1,242,915
Repayments on revolving credit (38,386) (1,421,895)
Repayments on long-term debt (5,982) (5,040)
Repayments on finance lease obligation (818) (585)
Exercise of stock options 9,504 4,626
Taxes paid on settlement of equity awards (4,819) (2,794)
Common stock repurchased, including excise tax (81,259) (21,168)
Net cash used in financing activities (83,424) (203,941)
Effect of exchange rate changes on cash and cash equivalents (580) (788)
(Decrease) increase in cash and cash equivalents (39,173) 122,872
Cash and cash equivalents at beginning of period 185,460 36,178
Cash and cash equivalents at end of period $ 146,287 $ 159,050